Monte Rosa Therapeutics, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Monte Rosa Therapeutics, Inc. (GLUE) is 853.91M

According to Monte Rosa Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 853.91M. This represents a change of -24.15% compared to the average of 1.13B of the last 4 quarters.

Monte Rosa Therapeutics, Inc. (GLUE) Historical Enterprise Value (quarterly & annually)

How has GLUE Enterprise Value performed in the past?

The mean historical Enterprise Value of Monte Rosa Therapeutics, Inc. over the last ten years is 616.75M. The current 853.91M Enterprise Value has changed 38.45% with respect to the historical average. Over the past ten years (40 quarters), GLUE's Enterprise Value was at its highest in in the June 2026 quarter at 2.01B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Monte Rosa Therapeutics, Inc. (GLUE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Monte Rosa Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Monte Rosa Therapeutics, Inc. (GLUE) Average Enterprise Value

How has GLUE Enterprise Value performed in the past?

The current Enterprise Value of Monte Rosa Therapeutics, Inc. (GLUE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Monte Rosa Therapeutics, Inc. (GLUE) Enterprise Value vs. Peers

How is GLUE’s Enterprise Value compared to its peers?

Monte Rosa Therapeutics, Inc.’s Enterprise Value is greater than C4 Therapeutics, Inc. (381.15M), less than Nurix Therapeutics, Inc. (2.16B), greater than Arvinas, Inc. (399.43M),

Build a custom stock screener for Monte Rosa Therapeutics, Inc. (GLUE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Monte Rosa Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Monte Rosa Therapeutics, Inc. (GLUE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Monte Rosa Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.